My "epidemic of war"
Release time:
2020-07-22
My "War Epidemic "
5# August 10 , three days before I returned to Guizhou Peak after my internship, I was ill.
I felt uncomfortable on the night shift. I thought it would be good to sleep, but it became more and more serious. my temperature soared to 38.6 ℃ ! What a terrible thing this is at this extraordinary time! Although I know very well in my heart that medicine is now so advanced that even if I hit the new coronavirus, it can be cured, but all the news I have experienced and heard about the global "epidemic " over the past few months, it is impossible to say that there is no pressure. Not afraid of your jokes, when I saw the numbers on the thermometer, the first sentence that came to my mind was, "Chen Xiaomin, aged 23 " .
Colleague Zhang Jie also had the same symptoms as me. She cried. She is a mother, a wife and a daughter, so she worries a lot. I understand her mood very well, but am I not the same myself? I think I am strong enough to pretend to be calm and calm, but I am so flustered that I dare not tell my family for fear that they are worried. Looking at the phone calls from colleagues and family members one by one, my heart was empty, as if I had no relatives around me. After sorting out the mood, I finally couldn't help calling home and chatting. Tears poured up and I couldn't stop sobbing. During the internship has been trying to overcome the unaccustomed life, but also suddenly burst out, let me very homesick. From the beginning of the internship, I was looking forward to going home, and finally I was almost there, but there was such a problem. I was so afraid that I couldn't go home.
I Baidu a lot of information, high fever does not subside, diarrhea, dry cough and fever, these are consistent with the new crown symptoms. And our situation has also attracted everyone's attention. For a while, not only Daye Peak was extremely nervous, but it was quickly disinfected. Even the leaders of Guizhou Peak hundreds of kilometers away were alarmed. Colleagues Orchid and Xiaolong returned to the dormitory for isolation. Zhang Jie and I were admitted to the hospital. To be honest, I am not afraid of being infected with the new coronavirus. What puts pressure on me is more physical and mental discomfort. I am afraid of pain, afraid of everyone's resistance to us, afraid of being blamed for bringing the virus to others, afraid of relatives afraid of seeing us ...... Because of all this fear, I can finally truly understand the feelings of the new coronary pneumonia patients. Many things cannot be expressed in words. You have to experience them yourself.
On the first day of admission, I was very tossed. My body temperature dropped and rose, and I was checked by the doctor again. I couldn't sleep all night. Looking at the empty room, I couldn't help feeling scared, so I got up and wiped all the places that the medical alcohol handle in the corridor often touched. Lying on the bed, the quilt is very thick, hot, and dare not kick away, although the clothes have been soaked with sweat, also dare not. I don't want to inconvenience others. Although wearing a mask is very sultry, I have to wear it even if I sleep in my room. When the nurse changed medicine to measure her temperature, I also tried not to touch her and left her some space. The days of hospitalization were really hard, counting the seconds. On the evening of
11 , Zhang Jie's fever completely subsided and her physical condition was normal, while I was still over 38 degrees, and my mood was absolutely terrible. I'm afraid I won't get better, I'm afraid I'll still be in the hospital after she's out of the hospital, and even more afraid, maybe I really got a new crown? Finally, the final test results came out, the nucleic acid test results showed negative, I couldn't help but cry with joy, holding the phone to reply to everyone's messages one by one. Talking to colleagues about "Chen Xiaomin died at 23 " made everyone burst into laughter, and I couldn't help laughing. Yes, I just want to make everyone laugh, relieve the tension these days, and celebrate that everyone can go home together after discharge.
Although it was only a false alarm, I cannot forget that when Master Beijie learned that I had a fever, she immediately called her husband to send me a thermometer. During the hospitalization, the leaders, colleagues and teachers of Daye Peak and Guizhou Peak were worried about our bad food, our unaccustomed life, and gave us food and daily necessities, every day many times to ask our situation ...... these information are too much to reply, I really feel the warmth of home.
's internship in daye peak is a very rare learning opportunity. after this special "war epidemic " , I have deeply imprinted all the stories that happened here in my mind and believe that I will never forget them in my life. Here, I feel the warmth of the spike family. When I needed comfort and help most, it was the spikes that gave me spiritual comfort and moved me much. I'm going to say "Thank you " to all the spikes.
Because of this experience, I also have a special feeling about the new crown epidemic. I sincerely hope that this disaster will end soon, and I believe that as long as we unite as one, we will be able to defeat the new coronavirus and reappear a healthy and beautiful China. Come on, China! (chen xiaomin)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31